CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.727
+0.066 (9.98%)
At close: Mar 6, 2026, 4:00 PM EST
0.759
+0.032 (4.37%)
After-hours: Mar 6, 2026, 7:59 PM EST
CalciMedica Employees
CalciMedica had 14 employees as of December 31, 2024. The number of employees increased by 2 or 16.67% compared to the previous year.
Employees
14
Change
2
Growth
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,970,800
Market Cap
11.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | 2 | 16.67% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 61 |
| CytoMed Therapeutics | 43 |
| Imunon | 25 |
| BiomX | 20 |
| BioCardia | 20 |
| Soligenix | 16 |
| Cellectar Biosciences | 11 |
| Akari Therapeutics, | 9 |
CALC News
- 4 days ago - CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - PRNewsWire
- 5 weeks ago - CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - Benzinga
- 5 weeks ago - CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - PRNewsWire
- 4 months ago - CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 4 months ago - CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension - PRNewsWire
- 4 months ago - CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 - PRNewsWire
- 5 months ago - CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ - PRNewsWire
- 6 months ago - CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire